Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5040243 | 6075327 | I | 5040243-X | 20060622 | 20060630 | EXP | US-NOVOPROD-254337 | NOVOPROD | F | Y | 20060630 | CN | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5040243 | 1007430366 | PS | NOVOLOG MIX 70/30 | 1 | SUBCUTANEOUS | UNKNOWN | UNKNOWN | 021172 | |||
| 5040243 | 1007430367 | SS | ATENOLOL | 1 | ORAL | UNKNOWN |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5040243 | 1007430366 | DIABETES MELLITUS |
| 5040243 | 1007430367 | ILL-DEFINED DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5040243 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5040243 | RASH |
| 5040243 | WHITE BLOOD CELL COUNT INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5040243 | 1007430366 | 20051101 |